The dispute over N Chandrasekaran's return is real. But the larger question is how much of the Trusts' control can survive a Tata Sons listing, and on what terms.
The Tata trusts collectively own about 66% of Tata Sons. In August, however, they could not cast a single vote at its annual general meeting.
The 18 August meeting was adjourned for want of quorum. The company's articles require a representative jointly nominated by Sir Dorabji Tata Trust and Sir Ratan Tata Trust, which together hold about 52%. SRTT is restrained from holding trustee meetings while proceedings before the Maharashtra Charity Commissioner continue. No trustee meeting meant no nomination, and no nomination meant no quorum. The AGM deadline has since been extended to December. For now, the controlling shareholder cannot exercise the control its shares appear to confer.
Read the rest of this dispute against that fact. Three dates explain it, and only one has consumed the argument.
On 12 August, N Chandrasekaran told the Tata Sons board he would not seek a third term as chairman. On 11 September, the Reserve Bank of India rejected Tata Sons' application to surrender its registration as a core investment company. On 17 September, the board reappointed him for five years by four votes to one and decided to initiate steps towards compliance with the RBI framework.
He said he would leave. The regulator spoke. The board asked him to stay.
The argument since then has centered around 17 September. Tata Trusts says Article 121 required the affirmative vote of a majority of its two nominee directors; that a majority among two is two; and that Noel Tata's dissent made the reappointment void. Tata Sons relies on the 4-1 board vote. The same objection may shadow the decision to move towards regulatory compliance. These are serious questions, but not the whole contest.
The identity of the chairman plainly matters as that office will engage with the RBI, shape the listing process, choose advisers and place proposals before the board. Tata Trusts is therefore not irrational to fight over the office. But the chairmanship is an instrument, not the outcome. Even a chairman preferred by the Trusts cannot vote away the regulatory problem.
Assume the Trusts win completely on the interpretation of Article 121. The resolution falls and the selection process begins again. The Trusts would still hold 66% of a company classified as an upper-layer NBFC, whose attempt to exit that framework has been rejected. Unless Tata Sons succeeds in court or persuades the RBI to accept another route to compliance, a listing is now the default regulatory outcome. The Trusts may win the argument over who holds the wheel without deciding where the company must go.
The Trusts want Tata Sons to remain unlisted; they recorded that position in a resolution last year. But this is the one thing 66% cannot secure by itself. A shareholder, however large, cannot outvote the Reserve Bank of India.
Listing would not automatically extinguish the Trusts' special rights. It would, however, change the ground beneath them. Regulation 31B of SEBI's listing regulations requires special rights granted to shareholders to be approved by special resolution every five years. Article 121 would therefore cease to be a protection secured only inside the articles. It would become a protection that must periodically be justified to public shareholders.
The deadlock also exposes a fundamental weakness. Under Ratan Tata, the same person chaired Tata Trusts and Tata Sons. Separating the offices had an understandable governance case: philanthropy and business should not depend on one individual. But it removed a common center without creating a mechanism to resolve disagreement between the institutions. Goodwill was doing work that machinery should have done. The articles explain precisely how a decision can be stopped, but much less clearly how an institutional disagreement must end.
Trustees of a public charitable trust hold their shares for beneficiaries. The case for keeping Tata Sons unlisted is control, and it is a real case: control has protected a dividend stream that has funded hospitals, schools and scholarships for decades. The case for listing is value, and that is real too: a listing could enlarge the corpus permanently. When control and value point in opposite directions, which one does a trustee owe a duty to? That question belongs to the Charity Commissioner, not to the NCLT, and it is far more uncomfortable for the Trusts than anything Article 121 can produce.
In a recent year, the Trusts' share of Tata Sons' declared dividend was about Rs 1,731 crore. The people and institutions supported by that income are the reason this governance contest matters. The relevant measure of success is not which side wins the next court battle, but which settlement best preserves the Trusts' capacity to fund them over decades.
The Trusts should therefore stop treating the chairmanship as the destination and use the contest as leverage in the larger negotiation. The real bargain concerns the timing and extent of dilution, the survival of nominee and reserved-matter rights, a workable dividend policy, and a deadlock mechanism that does not again leave a 66% shareholder unable to act. Those questions remain open. The Trusts can still shape their answers.
Every month spent proving that Article 121 can stop one resolution is a month lost deciding what Article 121 should become after listing. Tata Sons once went to the Supreme Court to preserve these protections for the Trusts. It would be a poor outcome if the Trusts spent their leverage on a chairmanship at the precise moment they needed it for something considerably larger.
Author is an Advocate practicing in Delhi. Views are personal.